Viva Biotech Holdings (HKG:1873)
Hong Kong · Delayed Price · Currency is HKD 1.850
+0.250 (15.63%)
Aug 8, 2025, 4:08 PM HKT
Viva Biotech Holdings Employees
Viva Biotech Holdings had 2,063 employees as of December 31, 2024. The number of employees decreased by 14 or -0.67% compared to the previous year.
Employees
2,063
Change (1Y)
-14
Growth (1Y)
-0.67%
Revenue / Employee
$1,024,789
Profits / Employee
$86,296
Market Cap
3.90B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 2,063 | -14 | -0.67% |
| Dec 31, 2023 | 2,077 | -524 | -20.15% |
| Dec 31, 2022 | 2,601 | 474 | 22.28% |
| Dec 31, 2021 | 2,127 | 508 | 31.38% |
| Dec 31, 2020 | 1,619 | 888 | 121.48% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| BeOne Medicines | 11,000 |
| Hansoh Pharmaceutical Group Company | 8,989 |
| JD Health International | 3,564 |
| Innovent Biologics | 5,659 |
| Akeso | 3,035 |
| Sino Biopharmaceutical | 24,379 |
| WuXi Biologics | 12,575 |
| CSPC Pharmaceutical Group | 21,400 |
Viva Biotech Holdings News
- 4 months ago - Viva Biotech's Wholly-Owned Subsidiary Langhua Pharmaceutical Successfully Passes U.S. FDA On-Site Inspection - PRNewsWire
- 4 months ago - Viva Biotech Announces 2024 Annual Results: Significantly Rebounding in Performance with New Stage ahead, AI Leads to a New Era of Novel Drug R&D - PRNewsWire
- 8 months ago - Viva Biotech Officially Establishes Boston Branch, Marking Another Milestone in Global Expansion - PRNewsWire
- 1 year ago - Viva Biotech Announces Its 2024 Interim Results: Significant Improvement in Net Profit Growth and Ongoing Optimization of Emerging Technology Platforms - PRNewsWire
- 1 year ago - Viva Biotech (1873.HK) Announces 2023 Annual Results: Successful Implementation of Light-asset Strategy, Achieving Solid Growth and Promising Future - PRNewsWire
- 1 year ago - Viva Biotech Secures Approximately US$ 210 Million Funding - PRNewsWire
- 2 years ago - Viva Biotech (1873.HK) Announces 2023 Interim Results: Solid Growth in Main Business, Significant Rebound in Profitability - PRNewsWire
- 2 years ago - Viva Biotech's Portfolio Company Riparian Pharmaceuticals Announces Exclusive License Agreement and Research Agreement with Pfizer for Novel Cardiovascular Programs - PRNewsWire